Synapse - Heather Landau

Results (420)

Al amyloidosis in a patient with a T60A TTR mutation

Book Section

Landau, H. J.; Comenzo, R. L.; Zhou, P.; Clark, B.; Teruya-Feldstein, J.; Wang, S.; Murphy, C. L.; Solomon, A.
In Skinner, M.; Berk, J. L.; Connors, L. H.; Seldin, D. C. (Eds.) XIth International Symposium on Amyloidosis (2008)

Fulltext@MSK | Save

CD32B expression reflects phenotypic and functional heterogeneity in multiple myeloma (MM)

Meeting Abstract

Zhou, P.; Boruchov, A. M.; Hoffman, J. E.; Mo, Q. X.; Olshen, A.; Glasner, E.; Bonvini, E.; Koenig, S.; Drieghe, E.; Fleisher, M.; more...
Blood (2008)

Fulltext@MSK | Save

Sequential administration of bortezomib, liposomal doxorubicin and dexamethasone (BDD) followed by thalidomide and dexamethasone (TD) results in rapid control of untreated high-risk multiple myeloma (MM) and improves depth of response

Meeting Abstract

Landau, H.; Hassoun, H.; Cohen, A.; Hoover, E.; Kewalramani, T.; Boruchov, A.; Klimek, V.; Reich, L.; Riedel, E.; Pandit-Taskar, N.; more...
Blood (2008)

Fulltext@MSK | Save

Early adjuvant treatment after risk-adapted autologous stem cell transplant for systemic light-chain amyloidosis: Increased hospitalizations and impaired immune recovery but improved responses and overall survival

Meeting Abstract

Hoffman, J. E.; Hassoun, H.; Landau, H.; Hoover, E.; Cohen, A.; Nimer, S.; Comenzo, R.
Blood (2008)

Fulltext@MSK | Save

Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone

Journal Article

Lebovic, D.; Hoffman, J.; Levine, B. M.; Hassoun, H.; Landau, H.; Goldsmith, Y.; Maurer, M. S.; Steingart, R. M.; Cohen, A. D.; Comenzo, R. L.
British Journal of Haematology (2008)

Fulltext@MSK | Save

High dose chemotherapy and autologous stem cell transplantation with melphalan in patients with monoclonal immunoglobulin deposition disease associated with multiple myeloma